XiaoEr LianHuaQinqGan alleviates viral pneumonia in mice infected by influenza A and respiratory syncytial viruses

CONCLUSION: XELH efficacy partially depends on integrated immunoregulatory effects. XELH is a promising therapeutic option against childhood respiratory viral infections.PMID:36444944 | DOI:10.1080/13880209.2022.2147961

Source: Pharmaceutical Biology - November 29, 2022 Category: Drugs & Pharmacology Authors: Wenyan Li Tongtong Li Chi Zhao Tao Song Yao Mi Zhang Chuangfeng Yunlong Hou Zhenhua Jia Source Type: research